Showing 8,781 - 8,800 results of 32,204 for search '(( a step decrease ) OR ( 50 ((((nn decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.02s Refine Results
  1. 8781

    Enantiomeric Deoxycholic Acid:  Total Synthesis, Characterization, and Preliminary Toxicity toward Colon Cancer Cell Lines by Bryson W. Katona (2465581)

    Published 2007
    “…Using a modified method of the synthesis of <i>ent</i>-testosterone that proceeds through the (<i>R</i>)-(−)-Hajos−Parrish ketone, we have completed the successful synthesis of <i>ent</i>-DCA in 25 steps with a yield of 0.3% with all stereochemical assignments of the product confirmed by X-ray crystallography. …”
  2. 8782

    Lists of predicted adverse events. by Soohyun Wi (18536612)

    Published 2024
    “…The early rehabilitation of critically ill patients can reduce the ICU-AW. We designed a protocol to investigate the feasibility and safety of conventional rehabilitation with additional in-bed cycling/stepping in critically ill patients.…”
  3. 8783

    Clinical examination items. by Soohyun Wi (18536612)

    Published 2024
    “…The early rehabilitation of critically ill patients can reduce the ICU-AW. We designed a protocol to investigate the feasibility and safety of conventional rehabilitation with additional in-bed cycling/stepping in critically ill patients.…”
  4. 8784

    Inclusion and exclusion criteria. by Soohyun Wi (18536612)

    Published 2024
    “…The early rehabilitation of critically ill patients can reduce the ICU-AW. We designed a protocol to investigate the feasibility and safety of conventional rehabilitation with additional in-bed cycling/stepping in critically ill patients.…”
  5. 8785

    Effect of Cytosolic pH on Inward Currents Reveals Structural Characteristics of the Proton Transport Cycle in the Influenza A Protein M2 in Cell-Free Membrane Patches of <i>Xenopus... by Mattia L. DiFrancesco (364045)

    Published 2014
    “…Assuming an additional transport step as e.g. caused by a constriction zone at Val27 resulted in a negligible improvement. …”
  6. 8786
  7. 8787

    Activity of miR-124 and miR-23a in NSC-derived neurons and astrocytes. by Annalisa Lattanzi (427545)

    Published 2013
    “…(B–E) A significant decrease of GFP expression is observed in bdLV.miRT124-transduced neurons (βtubIII, MAP2) (<b>B, C</b>) and in bdLV.miRT23a-transduced astrocytes (GFAP) and immature glial cells (nestin) (<b>D, E</b>). …”
  8. 8788
  9. 8789
  10. 8790
  11. 8791

    The effect of glibenclamide on channel activity at +20, 0 and -20 mV. by Sajjad Salari (736104)

    Published 2015
    “…Histogram bars show current amplitudes and P<sub>o</sub> of reconstituted channels in absence or presence of glibenclamide. The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P<sub>o</sub>. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”
  12. 8792
  13. 8793

    Crystal Structure of YbCu<sub>6</sub>In<sub>6</sub> and Mixed Valence Behavior of Yb in YbCu<sub>6–<i>x</i></sub>In<sub>6+<i>x</i></sub> (<i>x</i> = 0, 1, and 2) Solid Solution by Udumula Subbarao (1431364)

    Published 2016
    “…A deviation in inverse susceptibility data at 200 K suggests a valence transition from Yb<sup>2+</sup> to Yb<sup>3+</sup> as the temperature decreases. …”
  14. 8794
  15. 8795
  16. 8796

    Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  17. 8797

    Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  18. 8798

    Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  19. 8799

    Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  20. 8800

    Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”